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Abstract 
Studies in clinical and aging populations support associations between immunological 
function, cognition and mood, although these are not always in line with animal models. 
Moreover, very little is known about the relationship between immunological measures and 
cognition in healthy young adults. The present study tested associations between the state of 
immunological functionimmune system and memory recall in a group of relatively healthy 
adults. Immediate and delayed memory recall was assessed in 30 participants using the 
computerised cognitive battery. CD4, CD8 and CD69 subpopulations of lymphocytes, 
Interleukin-6 (IL-6) and cortisol were assessed with blood assays. Correlation analysis showed 
significant negative relationships between CD4 and the short and long delay memory 
measures. IL-6 showed a significant positive correlation with long-delay recall. Generalized 
linear models found associations between differences in all recall challenges and CD4. A 
multivariate generalized linear model including CD4 and IL-6 exhibited a stronger 
association. Results highlight the interactions between CD4 and IL-6 in relation to memory 
function. Further study is necessary to determine the underlying mechanisms of the 
associations between the state of immune system and cognitive performance.  
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1. Introduction  
A complex network of bidirectional signals exchanged between the nervous, endocrine and 
immune systems affect cognition and mood (Maier, 2003). For example, chronic stress 
induces the persistent activation of the hypothalamic-pituitary-adrenal axis and the autonomic 
nervous system, leading to the release of hormones (e.g. adrenaline, noradrenaline and 
cortisol) that induce quantitative and qualitative changes in the immune system (Glaser & 
Kiecolt-Glaser, 2005). Chronic activation of inflammatory pathways, on-the-other-hand, 
alters synthesis of certain neurotransmitters (e.g. serotonin), increasing stress responsivity and 
vulnerability to mood disorders (Kiecolt-Glaser, Derry, & Fagundes, 2015). Such alterations 
to neural chemistry would also be expected to affect several cognitive domains, including 
learning and memory (Švob Štrac, Pivac, & Mück-Šeler, 2016). Thus, the link between 
immune system function and cognition is supported in studies of stress (Aas et al., 2014), 
human immunodeficiency virus (HIV) (Hong & Banks, 2015), cancer (Andreotti, Root, Ahles, 
McEwen, & Compas, 2015), Alzheimer’s disease (Raskin, Cummings, Hardy, Schuh, & A 
Dean, 2015) and healthy aging (Serre-Miranda et al., 2014). However, the relationship 
between immunological markers and memory in relatively healthy (nonclinical) young adults 
remains unclear. Nevertheless, its investigation has important theoretical implications and 
practical utility with regard to advising on optimum immunological function for psychological 
wellbeing.  
One of the most important components of the adaptive immune response is the lymphocytes, 
such as T and B lymphocytes. T lymphocytes, or T cells, play a pivotal role in cell-mediated 
immunity. Primary T cells include helper, killer, regulatory types. T helper cells (TH cells) 
are involved in the maturation of B cells into antibody producing plasma cells (humoral 
immunity of the adaptive immune system) and activation of cytotoxic T cells and 
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macrophages. These TH cells are also known as CD4+ T cells because they express the CD4 
glycoprotein on their surfaces. Once activated, TH cells divide rapidly and produce cytokines 
that regulate the immune response. Killer T cells (e.g. CD8+ T) kill tumor cells, cells that are 
infected (particularly with viruses) and/or damaged cells through complex interactions of 
molecules between those expressed on the surface of the T cells and derived from antigen-
presenting cells.  Multiple surface proteins are known to be upregulated during the immune 
activation process. CD69 is the earliest inducible surface antigen expressed on lymphocytes 
after T- or B-cell activation and is absent from resting lymphocytes. Recent evidence supports 
a regulatory role for CD69 in modulating the inflammatory response (Sancho, Gómez, & 
Sánchez-Madrid, 2005). 
Cytokines modulate the balance between humoral and cell-based immune responses, and 
regulate the responsiveness of other cell populations important for brain function (Maier & 
Watkins, 2003). For example, cytokines can influence the metabolism of neurotransmitters 
(e.g. serotonin, norepinephrine and dopamine) and alter neuroendocrine function. That is, 
acute Interleukin (IL)-2 administration enhances dopaminergic transmission, while systemic 
IL-6 administration induces increased noradrenergic and serotonergic transmission (Wilson, 
Finch, & Cohen, 2002). CD4+  T-cells regulate brain-derived neurotrophic factor (BDNF), a 
protein critical for synaptic plasticity and memory-processing (Lu et al., 2008), and contribute 
to the neurogenic microenvironment (Wolf et al., 2009). On-the-other-hand, excessive or 
sustained release of inflammatory cytokines produces neurotoxic effects on neurons and glial 
cells, at least in vitro (Allan & Rothwell, 2001; Hanisch, 2002). 
Animal studies support the importance of CD4+ T cells in hippocampal neurogenesis and 
memory (Jeon et al., 2016). However, levels of CD4+ cells have been inversely associated 
with memory recallimmediate and stored memory  in children infected with HIV (Ruisenor-
Escudero et al., 2016) and short-term verbal memory, verbal working memory in older adults 
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(Serre-Miranda et al., 2015). Other cells were also inversely associated with stored memory, 
including CD38+ and CD8+ (Ruisenor-Escudero et al., 2016). CD69 is also implicated in 
memory and has been found on monocytes derived from patients with Alzheimer’s disease 
(Kusdra, Rempel, Yaffe, & Pulliam, 2000). In women with major unipolar depression, which 
is associated with increases in IL-6, verbal memory performance is negatively associated with 
IL-6 plasma level after controlling for age, years of education and depression severity (Grassi-
Oliveira, Bauer, Pezzi, Teixeira, & Brietzke, 2011). Consistently, an aging population study 
reported that people with high IL-6 level exhibited poorer attention and sensory memory 
compared to those having a low level or normal levels of IL-6 (Elwan et al., 2003). These 
findings provide initial evidence for the relationship between biomarkers of the state of 
immune function system and cognitive function in aging and clinical populations. However, 
as mentioned, little is known about the relationship between the immune system and cognition 
in the general young adult population.  
The present study was designed to examine whether associations between a set of 
immunological measures and memory function observed in clinical populations are consistent 
in healthy populations. Three levels of memory recall were evaluated, including immediate, 
short- and long delay memory recall. In particular, given Given findings from Ruisenor-
Escudero et al. (2016) and Kusdra et al. (2000) we expected an inverse associations between 
memory recall and both CD4+ and CD8+. Given those of Grassi-Oliveira et al. (2011), we 
anticipated an inverse association between memory recall and IL-6. In addition, associations 
between memory and other measures of the state of immune systemfunction (cortisol, CD69) 
were explored.    
 
2. Materials and Methods  
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2.1 Participants  
Participants (n=30; 10 males, 20 females, Mage = 29.50 years, SDage = 11.97; Meducation = 15.50 
years, SDeducation =2.5) included undergraduate (n = 25), post-graduate (n = 4) students and 
staff (n = 1) from a university in Auckland, New Zealand who enrolled in a large study 
investigating the effect of mindfulness on brain function. All data currently reported were 
collected prior to their engagement in mindfulness practice and outside of the school exam 
period, to avoid any possible influence of exam stress on immune system functioning. 
Exclusion criteria included current severe depression, a history of serious brain injury, 
epilepsy, drug or alcohol problem, and current prescription of medication for psychiatric 
illness (e.g. anxiety, depression, schizophrenia). Current depression level was measured using 
the Depression subscale from the Depression, Anxiety and Stress scale (DASS; (Benjamini & 
Hochberg, 1995)) and the total score over 20 suggested severe or extremely severe depression. 
Students of members of the research team were also excluded. 
The ethnic makeup included, NZ European (n = 16), Indian (n = 3), Asian (n = 3), Māori (n 
=1), Pacific (n = 1), others (n = 4) and Not Specified (n = 2). Ethical approval was granted by 
Auckland University of Technology Ethics Committee, and written informed consent was 
given by all participants. Students were gifted a $20 voucher for their time contributed to the 
study. 
2.2 Memory recall and Recognition test 
Testing for immediate, short and long delay memory recall was taken during the normal office 
hour of a day s(9am-5pm). Immediate and delayed memory recall was assessed using an 
Internet-based cognitive battery ‘IntegNeuro’ (for details see www.brainresource.com). The 
‘IntegNeuro’ test battery has good validity and test-retest reliability (Kemp et al., 2005; Paul 
et al., 2005; Williams et al., 2010) and meets standardised norms pre-established in 1000 
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healthy participants (Clark et al., 2006). It has also been validated against traditional paper-
and-pencil neuropsychological tests of cognition (convergent validity measures >0.53) (Paul 
et al., 2005). This test battery was delivered using an IBM screen interfaced platform with 
standardised vocal and visual instructions. Instructions were delivered via stereo 
headphones/microphone at the beginning of each test. Participants were also given a practice 
set for each test to ensure they understood the instructions.  
In the first part, the participants were presented with a list of 12 words, which they were asked 
to memorise. The list was presented 4 times in total, and the participants were required to 
recall as many words as possible after each presentation. Immediate recall was measured as 
the average of the number of words recalled immediately after each presentation.  
The participants were then presented with a second list of 12 distracter words, in which none 
of the words were phonetically or semantically related to the first list, and asked to recall that 
second list. After this distraction, the participants were asked immediately to recall the 
previously presented words from the original list. Short delay recall was measured as the 
number of words recalled from the original list. Long delay recall was measured as the number 
of words recalled from the original list after a delay of approximately 25 minutes, during 
which time participants completed other cognitive tests.  
2.3 Blood samples 
Blood samples were taken between 10 am and 12:30 pm on a day different from that on which 
cognitive tests were performed. This was due to logistic reasons, to avoid the effects of 
cognitive test on immune response and minimise diurinal variation of circulating Interleukin- 
6 in humans (Nilsonne, Lekander, Åkerstedt, Axelsson, & Ingre, 2016). Also, cortisol levels 
were expected to be on the decline at this time (10:00-12:30), after the early morning peak 
(Levine, Zagoory-Sharon, Feldman, Lewis, & Weller, 2007). Nevertheless, evidence shows 
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that there is considerable consistency on immune responses to acute laboratory stressors 
induced by cognitive tasks across time and across similar tasks (Adler et al., 2002; Cohen & 
Hamrick, 2003). 
Blood samples were collected via venepuncture in K2EDTA tubes and tubes with gel SST for 
serum separation (Surgical Supplies Ltd., Auckland, New Zealand). The EDTA samples were 
immediately analysed for red and white blood cell counts, haematocrit and haemoglobin 
concentration on a Sysmex XT automated quantitative haematology analyser (Sysmex 
Corporation, Auckland, New Zealand). Tubes with separating gels were centrifuged at 4oC 
and 3000 rpm for 15 min.  Serum was then extracted, and samples were processed immediately 
or kept frozen at -20oC until later analysis. 
CD4, CD8 and CD69 subpopulations of lymphocytes were assessed with a Muse Cell 
Analyser (Merck Millipore, USA). The Muse Cell Analyser features miniaturised 
fluorescence detection and microcapillary technology for rapid, accurate and reliable 
quantitative cell analysis. Briefly, the Muse™ Human CD4 T Cell Kit allows for the detection 
and identification of lymphocytes and CD4 T lymphocytes using a specific CD4 antibody that 
identifies human helper/inducer CD4+ T cell (HLA Class II reactive) and recognizes a 60-
kDa surface antigen. The Muse Human CD8 T Cell Kit allows for the detection and 
identification of lymphocytes and CD8 T lymphocytes using a specific CD8 antibody that 
identifies a 68-kDa transmembrane glycoprotein (HLA Class I restricted). Finally, the Muse 
Human Lymphocyte CD69 Assay uses an anti-lymphocyte cocktail that identifies the total 
lymphocyte population and a specific antibody that binds to the CD69 early activation marker 
expressed on lymphocytes. T-cell concentration in cells/μL, T-cell percent of lymphocytes 
and total lymphocyte concentration in cells/μL were obtained for all subpopulations tested. 
All kits were used according to manufacturer's instructions for the processing of whole blood.  
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Cortisol and Interleukin-6 (IL-6) concentrations were calculated using specific assays on a 
cobas Modular E170 analyser (Roche Diagnostics, New Zealand). Total duration of assay was 
18 min based on the electrochemiluminescence principle using ruthenium-conjugated 
monoclonal antibodies. C-reactive protein (CRP) was measured on a cobas Modular P800 
(Roche Diagnostics, New Zealand) based on a Particle-enhanced immunoturbidimetric 
principle using latex particles coated with monoclonal anti-CRP antibodies. Quantitative 
results were determined via instrument-specific full point calibration curves for all assays.  
The detection limit was 1.5 pg/ml for IL-6. 
 
2.5 Statistical analyses   
Data were inspected for normality, and where data showed non-normality, log transformations 
were applied. Spearman’s Rho correlations were used to test associations between the memory 
measures and immunological markers given the skewness of the dataset. Immunological 
(CD4, CD8, CD69, CRP and IL-6) and memory variables (immediate, short- and long delay 
recall scores) were included in the statistical analysis. Due to multiple comparisons, alpha 
criteria were set using Benjamin and Hochberg’s (Benjamini & Hochberg, 1995) step-up 
procedure. Univariate generalized linear models, followed by multivariate models were 
developed, including jackknife analyses. Final models were selected that exhibited the lowest 
Bayesian Information Criteria (BIC). The statistical procedures were performed using Stata 
version 14.  
 
3. Results  
Table 1 shows the descriptive statistics for the sample as well as the memory scores and results 
from blood assay analysis. All of the memory scores were found to be significant with CD4 
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and IL-6, however, aAfter controlling for multiple comparisons using Benjamin Hochberg 
step-up procedure, the significant association between immediate recall and CD4 and between 
short delay recall and IL-6 disappeared. correlations between immunological, and memory 
variables revealed that On the other hand, CD4 showed significant negative relationships with 
short delay recall (r = -.53, p = .03) and long delay recall (r = -.54, p = .02). IL-6 showed a 
significant positive correlation with long delay recall (r = .46, p = .04). None of the memory 
scores were significantly correlated with CD8, CD69, CRP, or cortisol (Table 2 and Figure 1 
show these relationships)  
Tables 3, 4 and 5 show the results of the generalized linear models for immediate, short delay 
and long delay recall respectively. CD4 was significantly inversely associated with 
immediate, short delay and long delay. In addition, for short delay, significant associations 
were observed for IL-6 (positive) and CRP (inverse). Model 2 which included these 
parameters had a significantly better fit than the model with CD4 alone (X2 =14.00, df = 2, p 
= .007). Likewise, for long term delay, the model that included both CD4 and IL-6 had a better 
fit than that with CD4 alone (X2 =5.18, df = 1, p = .023). 
 
4. Discussion  
Evidence suggests that direct immune processes are controlled by changes in neural activity 
and, concomitantly, immune-derived induction of cytokines can interfere with brain function 
(Maier & Watkins, 2003). The current study investigated whether associations between 
immunological markers and memory recall observed in clinical populations are present in the 
general population. Results suggest memory recall is associated with CD4, IL-6 and CRP.  
The inverse association between CD4 and recall contrasts studies in animals, which generally 
suggests CD4 T cells play a supportive role in brain function, including hippocampal function, 
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neurogenesis and memory. For example, decreased brain-derived neurotrophic factor (BDNF) 
production has been found in the brains of the CD4-depleted mice (Wolf et al., 2009). 
However, the current results are in line with previous human studies, for example in children 
with HIV infection (Ruisenor-Escudero et al., 2016). Also, in a study in healthy aging, better 
performance in memory and executive function were found for those with lower blood-
derived CD4 T-cell counts and higher B-cell counts (Serre-Miranda et al., 2015). In that study, 
it was proposed that high CD4 T cells reflect a more proinflammatory profile, which could 
underpin poorer memory. In agreement with this, short delay recall was also inversely 
associated with CRP, a nonspecific marker of inflammation.  
 IL-6 was positively associated with long delay recall and strengthened the association of CD4 
with long delay recall. This is in line with animal studies which have shown that IL-6 increases 
serotoninergic and dopaminergic transmission in the hippocampus and promotes the survival 
of catacholaminergic neurons (Zalcman et al., 1994). Nonetheless, an inverse relationship 
between IL-6 and memory has been observed in clinical populations, such as people with 
dementia and major depression (Elwan et al., 2003; Grassi-Oliveira et al., 2011). Taken 
together, the presence of depression in clinical populations may mediate the relationships 
between immunological measures and cognition. IL-6 is typically raised in these populations, 
and it is possible that the role of IL-6 in memory varies based on the conditions or context in 
which it is elevated, as well as on the magnitude and duration of elevation. In support of this 
idea, memory function of patients with chronic fatigue syndrome or control subjects were 
unaffected by administration of IL-6 (Arnold et al., 2002), and surgical patients with elevated 
IL-6 levels exhibited less declines in declarative memory after surgery (Shapira-Lichter et al., 
2008). For systemic lupus erythematosus patients, those with higher levels of IL-6 exhibited 
higher learning scores (Kozora, Laudenslager, Lemieux, & West, 2001). An inverted U-shape 
relationship between IL-6 and cognitive function has been proposed, suggesting that cognition 
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may be facilitated by moderate levels of IL-6 but adversely affected when IL-6 levels are 
either very low or very high (Kozora et al., 2001). In our study, we only included healthy 
volunteers whose IL-6 levels are more likely to be moderate, and this may explain the 
observed positive association between IL-6 and memory. Furthermore, it should be noted that 
the involvement of IL-6 was only observed in delay recall, not in immediate recall, which 
suggestsand this may be due to  the involvement of there are separate neural circuits or 
memory store support in the short term and long term memory (Ranganath & Blumenfeld, 
2005).  
No strong correlations were observed between memory and either CD8, CD69 or cortisol, 
suggesting that none of these immunological markers are tightly linked to memory in our 
study group. The reasons for the absence of correlations between memory and these 
immunological measures are unclear and need to be further investigated in larger groups. 
Nevertheless, it has been shown that CD8+ T cell compartment remains functionally intact in 
mice exhibiting significant impaired performance in memory tasks (Radjavi, Smirnov, & 
Kipnis, 2014). The association between cortisol and memory is only observed in males but 
not in females (Wolf, Schommer, Hellhammer, McEwen, & Kirschbaum, 2001).  
As a limitation, the observational design of the study does not allow us to conclude that the 
link between immunological variables and memory performance represents a causal or time-
related relationship. Furthermore, there was unbalanced gender composition in our study 
sample, and there could be additional variables that we have not measured that affect both 
memory and the state of immune function system and that require further investigation, 
including gender, body mass index, smoking status or sickness during the test. Nevertheless, 
our findings support the further exploration of immunological markers and their possible 
associations and prediction of memory performance as warranted. Future studies should 
investigate a causal relationship by testing whether manipulation of CD4 and ILl-6 cell counts 
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affects memory. Eligibility for this study included healthy/non- clinical population. People 
with acute mental health conditions on medication (e.g. anxiety disorders, major depression, 
schizophrenia), and those with a history of traumatic brain injury, alcohol or substance abuse, 
epilepsy and psychotic disorder were excluded. The findings derived from a sample of 30, 
mainly young university students and may have limited generalisability to less educated, older 
or younger groups. Future research should compare across a range of demographics in clinical 
and non-clinical populations. Blood samples and memory evaluation were performed on 
separate days in order to minmise the effect of individual difference in response to task-related 
stress on the state of immune system. Nevertheless, it is important to characterize immune 
responses to acute task-related stress over a longer period time, such as magnitude of response, 
time to recovery to baseline, and time to return to a stable baseline. (Cohen & Hamrick, 2003). 
In summary, the current findings suggest that there are associations between immunological 
markers and memory. Early evaluation and intervention for cognitive problems may benefit 
from addressing the variations of these immunological makers. Further study is necessary to 
determine the underlying mechanisms of the associations between immune system and 
cognitive performance.  
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Table 1. Medians, interquartile ranges of demographics, immunological and memory 
measures (N = 30). 
  Median Interquartile 
range 
Age (years) 25 14 
Education (years) 15.50 2.0 
CD4 (cells/μL) 812.50 268.5 
CD8 (cells/μL) 493.50 259.5 
CD69 (cells/μL) 14.00 14.3 
IL-6 (pg/ml) 4.39 2.58 
CRP (mg/L)1 1.00 3.00 
Cortisol (nmol/L) 272.05 271.2 
Immediate recall2 33.50 5 
Short delay recall2 8.50 2 
Long delay recall2 8.00 3 
1C-Reactive Protein, 2Measured by number of words recalled. 
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Table 2. Correlations between immunological and memory measures1. 
  
1 2 3 4 5 6 7 8 9 
1.CD4 -         
2.CD8 .22 -        
3.CD69 -.07 .10 -       
4.IL-6 -.34 .01 -.20 -      
5.C- Reactive Protein -.23 .18 .03 .43 -     
6.Cortisol -.07 .05 -.00 -.37 .13 -    
7.Immediate recall -.45 .13 -.01 .16 -.19 .21 -   
8.Short delay recall -.53** .02 .00 .44 -.04 -.25 .58** -  
9.Long delay recall -.54** -.04 .21 .46* .07 -.25 .41 .70** - 
1P-values corrected for multiple comparisons (consider significant < 0.01 after correction). **Correlation is significant at the 0.01 
level (2-tailed). 
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Figure 1. Scatterplot Matrix depicting correlations between memory scores and immune 
function measures. 
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Table 3. Generalized linear model of total immediate recall trials (N = 30). 
Variable Exp(b) SE 
(Jackknife) 
T P CI 
CD4 0.898 0.004 2.77 <0.001 0.982 – 
0.997 
Constant 1.0518 3.3818 12.84 <0.001 1.4115 – 
7.7620 
Overall model fit:  AIC 17.634 BIC 17.634 
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Table 4. Generalized linear models of short delay recall. 
Model 1 Summary: 
Variable Exp(b) SE 
(Jackknife) 
T P CI 
CD4 0.994 0.001 4.19 <0.001 0.993 – 
0.997 
Constant 246,253.1 268,056.8 11.40 <0.001 26,576.9 -      
2,281,703 
Overall model fit:  AIC 3.708 BIC -32.553 
 
Model 2 Summary: 
Variable Exp(b) SE 
(Jackknife) 
T P CI 
CD4 0.996 0.001 2.79 0.009 0.993 – 
0.999 
CD8 1.002 0.001 1.47 0.152 0.999 – 
1.004 
IL6 2.222 0.450 3.94 < 0.001 1.468 – 
3.363 
CRP 0.774 0.063 3.17 0.004 0.656 – 
0.913 
Age 0.963 0.021 1.72 0.096 0.920 – 
1.007 
Constant 5,515.896 10150.63 4.68 <0.001 127.952 – 
237,785.3 
Overall model fit:  AIC 3.508 BIC -42.323 
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Table 5. Generalized linear models of long delay recall. 
Model 1 summary: 
Variable Exp(b) SE 
(Jackknife) 
T P CI 
CD4 0.994 0.001 4.97 <0.001 0.991 – 
0.997 
Constant 247,267.8 243,696.8 12.60 <0.001 32,943.02 -    
1,855,973 
Overall model fit:  AIC 4.445 BIC 35.707 
 
Model 2 Summary: 
Variable Exp(b) SE 
(Jackknife) 
T P CI 
CD4 0.995 0.001 4.28 <0.001 0.993 – 0.997 
IL6 1.757 0.498 1.99 0.057 0.983 – 3.139 
Constant 5,909.
252 
11,819.33 4.34 <0.001 98.843 -   
353,280.8 
Overall model fit:  AIC 4.339 BIC 18.350 
 
 
 
 
 
